Workshop III: Recommendations for future clinical trials
- 1 September 1992
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 3, S101-S104
- https://doi.org/10.1093/annonc/3.suppl_4.s101
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The clinical Significance of serum CD8 antigen levels in adult patients with Hodgkin's diseaseAnnals of Oncology, 1991
- Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's diseaseBlood, 1991
- Hodgkin's disease: The right doseInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.Journal of Clinical Oncology, 1990
- High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1990
- Cooperative trials of Hodgkin's lymphoma in the Federal Republic of GermanyZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- The never-ending controversies in Hodgkin's diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1989
- A step toward ending the controversies in Hodgkin's diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.Journal of Clinical Oncology, 1988
- Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centresBritish Journal of Cancer, 1988